Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters

被引:24
|
作者
Colabufo, Nicola A. [1 ]
Contino, Marialessandra [1 ]
Cantore, Mariangela [1 ,2 ]
Capparelli, Elena [1 ]
Perrone, Maria Grazia [1 ]
Cassano, Giuseppe [3 ]
Gasparre, Giuseppe [3 ]
Leopoldo, Marcello [1 ]
Berardi, Francesco [1 ]
Perrone, Roberto [1 ]
机构
[1] Univ Bari ALDO MORO, Dipartimento Farm, I-70125 Bari, Italy
[2] Natl Canc Inst, Clin Expt Oncol Lab, I-70124 Bari, Italy
[3] Univ Bari ALDO MORO, Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, I-70125 Bari, Italy
关键词
P-glycoprotein; Naphthalenyl derivatives; BCRP; MRP1; MDR revertant agents; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CANCER; INHIBITORS; MRP1; BCRP; RADIOTRACER; MODULATION; DESIGN; ASSAYS;
D O I
10.1016/j.bmc.2012.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substituted naphthalenyl derivatives bearing oxazole, or thiazole or furyl heteronuclei have been carried out as bioisosters of aryl-oxazoles and -thiazoles derivatives previously reported in order to investigate the role of the hindrance on the activity towards P-gp/BCRP/and MRP1 transporters. In addition, the role of naphthalenyl group to modulate P-gp intrinsic activity of these compounds was ascertained. The results demonstrated that all naphthalenyl derivatives displayed comparable P-gp activity with respect to lead compounds previously characterized in our SAR studies but were less active towards BCRP and MRP1 pumps. In terms of intrinsic activity, the replacement of aryl with naphthalenyl moiety led to P-gp inhibitors, unambiguous or ambiguous substrates on the base of the heteronucleus and the substituent on the naphthalenyl fragment. Indeed, oxazole derivatives were: inhibitors (R = H, F, OH), unambiguous substrates (R = OCH3), or ambiguous substrate (R = Br); thiazole derivatives were: unambiguous substrates (R = OCH3, Br), or ambiguous substrates (R = H, F). Finally furyl derivatives were ambiguous substrates. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1324 / 1332
页数:9
相关论文
共 50 条
  • [1] The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP
    Sun, Siyuan
    Chen, Zhongjian
    Li, Liping
    Sun, Dongli
    Tian, Ye
    Pan, Hao
    Bi, Huichang
    Huang, Min
    Zeng, Su
    Jiang, Huidi
    XENOBIOTICA, 2012, 42 (12) : 1197 - 1205
  • [2] 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells
    Ranjbar, Sara
    Khonkarn, Ruttiros
    Moreno, Alexis
    Baubichon-Cortay, Helene
    Miri, Ramin
    Khoshneviszadeh, Mehdi
    Saso, Luciano
    Edraki, Najmeh
    Falson, Pierre
    Firuzi, Omidreza
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 362 : 136 - 149
  • [3] Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
    Gameiro, Mariline
    Silva, Renata
    Rocha-Pereira, Carolina
    Carmo, Helena
    Carvalho, Felix
    Bastos, Maria de Lourdes
    Remiao, Fernando
    MOLECULES, 2017, 22 (04):
  • [4] Interaction of At1-Receptor Antagonists and Thiazolidindiones with the Atp-Binding Cassette Transporters P-Gp, Bcrp, Mrp1, and Mrp2
    Sauer, Alexandra
    Benndorf, Ralf
    Boeger, Rainer
    Haefeli, Walter Emil
    Weiss, Johanna
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 519 - 519
  • [5] P-gp、MRP1、BCRP在晚期NSCLC中的表达及意义
    王慧娟
    王启鸣
    樊青霞
    朱辉
    刘涛
    郭志强
    马智勇
    中国肿瘤, 2007, (12) : 1031 - 1034
  • [6] INVOLVEMENT OF p-GP AND MRP1 IN TRANSDERMAL DRUG PERMEATION
    Ito, Katsuaki
    Nguyen, Hai Thien
    Kato, Yukio
    Kubo, Yoshiyuki
    Tsuji, Akira
    DRUG METABOLISM REVIEWS, 2007, 39 : 179 - 180
  • [7] Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP
    Janneh, O
    Owen, A
    Chandler, B
    Hartkoorn, RC
    Hart, CA
    Bray, PG
    Ward, SA
    Back, DJ
    Khoo, SH
    AIDS, 2005, 19 (18) : 2097 - 2102
  • [8] ATP-binding cassette proteins BCRP, MRP1 and P-gp expression and localization in the human umbilical cord
    Riches, Zoe
    Walia, Gurinder
    Berman, Jacob M.
    Wright, Tricia E.
    Collier, Abby C.
    XENOBIOTICA, 2016, 46 (06) : 548 - 556
  • [9] EXPRESSION OF THE EFFLUX TRANSPORTERS MRP1 AND BCRP IN HEALTHY AND PREECLAMPTIC PLACENTAS
    Al-Lahham, Rabab
    Afrouzian, Marian
    Popov, Vsevolod
    Fischer, Wayne
    Ahmed, Mahmoud
    Nanovskaya, Tatiana
    PLACENTA, 2017, 57 : 279 - 280
  • [10] Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters
    Reznicek, Josef
    Ceckova, Martina
    Cerveny, Lukas
    Mueller, Fabian
    Staud, Frantisek
    XENOBIOTICA, 2017, 47 (01) : 77 - 85